Study of Bictegravir/Emtricitavine/Tenofovir Alafenamide in HIV-1 Infected naïve Patients Using Test and Treat Stategy Rapid-initiation Model of Care: BIC-NOW Clinical Trial (BIC-NOW)

PHASE4CompletedINTERVENTIONAL
Enrollment

208

Participants

Timeline

Start Date

October 27, 2020

Primary Completion Date

October 30, 2023

Study Completion Date

October 30, 2023

Conditions
HIV Infections
Interventions
DRUG

BIC/FTC/TAF

TEST and TREAT strategy: Study group will start the intervention at the first visit with their healthcare provider.

Trial Locations (15)

18008

Hospital Universitario Virgen de Las Nieves, Granada

18014

Hospital Campus de la Salud, Granada

Unknown

H JEREZ, Jerez de la Frontera

Hospital Universitario Torrecárdenas, Almería

Hospital Universitario Puerto Real, INIBICA,, Cadiz

Complejo Hospitalario de Jaén,, Jaén

Hospital Clínico San Carlos, Complutense University, CIBERINFEC ISCIII, Madrid, Spain, Madrid

Hu Infanta Leonor, Madrid

Hu La Princesa, Madrid

Ramon Y Cajal, Madrid

Hospital General Universitario Santa Lucía, Murcia

Hospital Universitario Virgen de la Arrixaca, IMIB,, Murcia

Hospital de Son Llàtzer, Palma de Mallorca

Hospital Clínico Universitario de Valencia, Valencia

HU la Fé, Valencia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

Carmen Hidalgo Tenorio

OTHER